speb/financial-data huggingface dataset:
Financial ratios for SCR.PA — annual report dated 2024-12-31
Total revenue: 16302083333.333334
Net income: 4166666.666666667
Capital expenditures: 8333333.333333334
Operating cash flow: 940625000
Depreciation & amortization: 232291666.6666667
Net tangible assets: 3322916666.666667
Owner earnings: 228125000
Return on net tangible assets (%): 6.8652037617554855
Buffett classification: The Gruesome
Stock price: 21.635416666666668
P/E ratio: 927.7096837299999
Shares outstanding: 178663396
Book value: 4712500000.000004
P/B ratio: 0.8202561306189207
Market cap (USD): 3865457015.541667
Debt to equity: 0.7844827586206891
Effective tax rate (%): 97.7401129943503
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 911458333.3333334
Buyback yield (%): 0.7545463977324693
Retained earnings: 4166666.666666667
Capitalized R&D asset: 0
FCF margin (%): 5.5910543130990416
Revenue growth (%): -7.3569804887289285
Rule of 40 score: -1.765926175629887
Financial ratios for SCR.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 3322916666.666667
Buffett classification: The Gruesome
Stock price: 21.635416666666668
Shares outstanding: 178663396
Book value: 4712500000.000004
P/B ratio: 0.8202561306189207
Market cap (USD): 3865457015.541667
Debt to equity: 0.7844827586206891
Buyback yield (%): 0
Retained earnings: 4166666.666666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCR.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 3817647058.8235297
Buffett classification: The Gruesome
Stock price: 30.988235294117647
Shares outstanding: 178663396
Book value: 4857647058.823532
P/B ratio: 1.1397417899346083
Market cap (USD): 5536463353.694118
Debt to equity: 0.807459433276822
Buyback yield (%): 0
Retained earnings: 500000000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCR.PA — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 3680000000
Buffett classification: The Gruesome
Stock price: 31.788235294117648
Shares outstanding: 178663396
Book value: 5208235294.117653
P/B ratio: 1.090464187919583
Market cap (USD): 5679394070.494118
Debt to equity: 0.8057375197650771
Buyback yield (%): 0
Retained earnings: 1001176470.5882354
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCR.PA — annual report dated 2025-12-31
Total revenue: 17411764705.882355
Net income: 1001176470.5882354
Capital expenditures: 28235294.11764706
Operating cash flow: 1375294117.647059
Depreciation & amortization: 298823529.41176474
Net tangible assets: 3680000000
Owner earnings: 1271764705.8823528
Return on net tangible assets (%): 34.55882352941176
Buffett classification: The Gruesome
Stock price: 31.788235294117648
P/E ratio: 5.672720281927145
Shares outstanding: 178663396
Book value: 5208235294.117653
P/B ratio: 1.090464187919583
Market cap (USD): 5679394070.494118
Debt to equity: 0.8057375197650771
Effective tax rate (%): 28.06424344885883
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 1329411764.7058823
Buyback yield (%): 1.0357360077788538
Retained earnings: 1001176470.5882354
Capitalized R&D asset: 0
FCF margin (%): 7.635135135135133
Revenue growth (%): 6.806991167073866
Rule of 40 score: 14.442126302209
Financial ratios for SLCO.PA — annual report dated 2021-12-31
Total revenue: 1172727.2727272727
Gross profit: -710227.2727272727
Operating income: -245454.54545454544
Net income: -594318.1818181818
Capital expenditures: 0
Operating cash flow: -393181.8181818182
Depreciation & amortization: -420454.54545454547
Net tangible assets: -35223863.63636363
Owner earnings: -1014772.7272727273
Buffett classification: The Gruesome
Stock price: 0.32954545454545453
Shares outstanding: 6208259
Book value: -35223863.63636363
Market cap (USD): 2045903.534090909
Debt to equity: -0.8795044681743395
Current ratio: 0.06276276276276276
Quick ratio: 0.06276276276276276
COGS to revenue (%): 160.56201550387595
Free cash flow (dilution-adjusted): -393181.8181818182
Buyback yield (%): 0
Retained earnings: -594318.1818181818
Capitalized R&D asset: 0
FCF margin (%): -33.52713178294574
Rule of 40 score: -33.52713178294574
Financial ratios for SLCO.PA — annual report dated 2022-12-31
Total revenue: 393617.02127659577
Gross profit: -107446.80851063831
Operating income: 145744.68085106384
Net income: -85106.38297872341
Capital expenditures: 0
Operating cash flow: -451063.8297872341
Depreciation & amortization: -279787.23404255323
Net tangible assets: -33060638.297872342
Owner earnings: -364893.6170212766
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.30851063829787234
Shares outstanding: 6208259
Book value: -33060638.29787234
Market cap (USD): 1915313.9468085107
Debt to equity: -0.887601763361972
Current ratio: 0.1266831547128332
Quick ratio: 0.1266831547128332
COGS to revenue (%): 127.2972972972973
Free cash flow (dilution-adjusted): -451063.8297872341
Buyback yield (%): 0
Retained earnings: -85106.38297872341
Receivables turnover: 0.8333333333333334
Capitalized R&D asset: 0
FCF margin (%): -114.5945945945946
Revenue growth (%): -66.43575787563913
Rule of 40 score: -181.0303524702337
Financial ratios for STBA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.59
Shares outstanding: 35976886
Market cap (USD): 956625398.74
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STBA — annual report dated 2022-12-31
Total revenue: 374042000
Net income: 135520000
Capital expenditures: 3702000
Operating cash flow: 240525000
Depreciation & amortization: 9027000
Net tangible assets: 805857000
Owner earnings: 140845000
Return on net tangible assets (%): 17.477666633161963
Buffett classification: The Gruesome
Stock price: 29.94
P/E ratio: 7.948258314935065
Shares outstanding: 35976886
Book value: 1184659000
P/B ratio: 0.9092472743971052
Market cap (USD): 1077147966.8400002
Debt to equity: 0.37073453204677465
Effective tax rate (%): 19.77742260107737
COGS to revenue (%): 0
SG&A to revenue (%): 29.856272824976877
Free cash flow (dilution-adjusted): 233474000
Buyback yield (%): 0.7840148484682998
Retained earnings: 863948000
Capitalized R&D asset: 0
FCF margin (%): 62.419193566497874
Rule of 40 score: 62.419193566497874
Financial ratios for STBA — annual report dated 2023-12-31
Total revenue: 407030000
Net income: 144781000
Capital expenditures: 5509000
Operating cash flow: 171749000
Depreciation & amortization: 7520000
Net tangible assets: 905962000
Owner earnings: 146792000
Return on net tangible assets (%): 16.2028870968098
Buffett classification: The Gruesome
Stock price: 30.56
P/E ratio: 7.593908290176198
Shares outstanding: 35976886
Book value: 1283445000
P/B ratio: 0.856642580056021
Market cap (USD): 1099453636.1599998
Debt to equity: 0.3924087124886536
Effective tax rate (%): 19.028097805418223
COGS to revenue (%): 0
SG&A to revenue (%): 29.99090976095128
Free cash flow (dilution-adjusted): 162366000
Buyback yield (%): 1.8742036337220571
Retained earnings: 959604000
Capitalized R&D asset: 0
FCF margin (%): 39.890425767142474
Revenue growth (%): 8.819330449521711
Rule of 40 score: 48.70975621666419
Financial ratios for STBA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.52
Shares outstanding: 35976886
Market cap (USD): 1421806534.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STBA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.27
Shares outstanding: 35976886
Market cap (USD): 1304881655.22
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STBA — annual report dated 2024-12-31
Total revenue: 383889000
Net income: 131265000
Capital expenditures: 2936000
Operating cash flow: 173367000
Depreciation & amortization: 10865000
Net tangible assets: 1003815000
Owner earnings: 139194000
Return on net tangible assets (%): 13.866499305150851
Buffett classification: The Gruesome
Stock price: 36.27
P/E ratio: 9.940819374700036
Shares outstanding: 35976886
Book value: 1380294000
P/B ratio: 0.9453650129754967
Market cap (USD): 1304881655.22
Debt to equity: 0.1813483214445618
Effective tax rate (%): 20.35760657209771
COGS to revenue (%): 0
SG&A to revenue (%): 34.52612604164224
Free cash flow (dilution-adjusted): 165809000
Buyback yield (%): 0.06667271292532041
Retained earnings: 1039035000
Capitalized R&D asset: 0
FCF margin (%): 43.19191224546679
Revenue growth (%): -5.68533031963246
Rule of 40 score: 37.506581925834325
Financial ratios for STBA — quarterly report dated 2025-03-31
Total revenue: 93752000
Net income: 33401000
Capital expenditures: 1726000
Operating cash flow: 28910000
Net tangible assets: 1041797000
Owner earnings: 31675000
Return on net tangible assets (%): 3.040419582701812
Buffett classification: The Gruesome
Stock price: 35.46
P/E ratio: 9.54866903356187
Shares outstanding: 35976886
Book value: 1418034000
P/B ratio: 0.8996542942975979
Market cap (USD): 1275740377.56
Debt to equity: 0.1377322405527653
Effective tax rate (%): 19.90359943406633
COGS to revenue (%): 0
SG&A to revenue (%): 34.67446027818073
Free cash flow (dilution-adjusted): 27184000
Buyback yield (%): 0.0032138200468669973
Retained earnings: 1059367000
Capitalized R&D asset: 0
FCF margin (%): 28.995648092840685
Rule of 40 score: 28.995648092840685
Financial ratios for STBA — quarterly report dated 2025-06-30
Total revenue: 100072000
Net income: 31900000
Capital expenditures: 1190000
Operating cash flow: 28066000
Net tangible assets: 1069413000
Owner earnings: 30710000
Return on net tangible assets (%): 2.8716688501074885
Buffett classification: The Gruesome
Stock price: 36.52
P/E ratio: 20.12030254850615
Shares outstanding: 35976886
Book value: 1445493000
P/B ratio: 0.9089465509137713
Market cap (USD): 1313875876.72
Debt to equity: 0.17316168255397985
Effective tax rate (%): 20.218087234893957
COGS to revenue (%): 0
SG&A to revenue (%): 35.43348788872012
Free cash flow (dilution-adjusted): 26876000
Buyback yield (%): 0.1137854820603118
Retained earnings: 1078166000
Capitalized R&D asset: 0
FCF margin (%): 26.856663202494204
Revenue growth (%): 6.741189521290212
Rule of 40 score: 33.59785272378441
Financial ratios for STBA — quarterly report dated 2025-09-30
Total revenue: 103004000
Net income: 34962000
Capital expenditures: 604000
Operating cash flow: 40489000
Net tangible assets: 1099592000
Owner earnings: 34358000
Return on net tangible assets (%): 3.124613493004678
Buffett classification: The Gruesome
Stock price: 36.63
P/E ratio: 13.143765239220851
Shares outstanding: 35976886
Book value: 1475466000
P/B ratio: 0.8931641489400638
Market cap (USD): 1317833334.18
Debt to equity: 0.15947436267592746
Effective tax rate (%): 20.243635368190528
COGS to revenue (%): 0
SG&A to revenue (%): 33.49966991573143
Free cash flow (dilution-adjusted): 39885000
Buyback yield (%): 0.009788794732550008
Retained earnings: 1100028000
Capitalized R&D asset: 0
FCF margin (%): 38.72179721175877
Revenue growth (%): 2.9298904788552242
Rule of 40 score: 41.651687690614
Financial ratios for STBA — quarterly report dated 2025-12-31
Total revenue: 105291000
Net income: 33967000
Capital expenditures: 1248000
Operating cash flow: 36151000
Net tangible assets: 1088202000
Owner earnings: 32719000
Return on net tangible assets (%): 3.006702799664033
Buffett classification: The Gruesome
Stock price: 38.7
P/E ratio: 10.372535857855919
Shares outstanding: 35976886
Book value: 1463877000
P/B ratio: 0.9511082476191648
Market cap (USD): 1392305488.2
Debt to equity: 0.18122629155318376
Effective tax rate (%): 19.925033593436904
COGS to revenue (%): 0
SG&A to revenue (%): 33.54037856986827
Free cash flow (dilution-adjusted): 34903000
Buyback yield (%): 2.605821804732293
Retained earnings: 1120297000
Capitalized R&D asset: 0
FCF margin (%): 33.14908206779307
Revenue growth (%): 2.220302124189352
Rule of 40 score: 35.36938419198242
Financial ratios for STBA — annual report dated 2025-12-31
Total revenue: 402119000
Net income: 134230000
Capital expenditures: 4768000
Operating cash flow: 133616000
Depreciation & amortization: 10445000
Net tangible assets: 1088202000
Owner earnings: 139907000
Return on net tangible assets (%): 12.856712264818482
Buffett classification: The Gruesome
Stock price: 38.7
P/E ratio: 10.372535857855919
Shares outstanding: 35976886
Book value: 1463877000
P/B ratio: 0.9511082476191648
Market cap (USD): 1392305488.2
Debt to equity: 0.18122629155318376
Effective tax rate (%): 20.07264499225914
COGS to revenue (%): 0
SG&A to revenue (%): 34.265478626973604
Free cash flow (dilution-adjusted): 123504000
Buyback yield (%): 2.725407629403037
Retained earnings: 1120297000
Capitalized R&D asset: 0
FCF margin (%): 30.713296312783033
Revenue growth (%): 4.74876852423487
Rule of 40 score: 35.462064837017905
Financial ratios for TAM.L — annual report dated 2022-03-31
Total revenue: 38626315.78947368
Operating income: 15302631.578947369
Net income: 12160526.315789474
Capital expenditures: 97368.42105263157
Operating cash flow: 17946052.63157895
Depreciation & amortization: 1201315.7894736843
Net tangible assets: 23236842.10526316
Owner earnings: 13264473.684210528
Return on net tangible assets (%): 57.08380520951303
Capex to operating income (%): 0.6362854686156492
Buffett classification: The Great
Stock price: 0.05105263157894737
P/E ratio: 0.2548616707639039
Shares outstanding: 60706999
Book value: 40847368.421052635
P/B ratio: 0.0758739711763948
Market cap (USD): 3099252.0542105264
Debt to equity: 0
Current ratio: 3.490338803599788
Quick ratio: 3.490338803599788
Effective tax rate (%): 18.031042128603104
Interest coverage ratio: 32.760563380281695
COGS to revenue (%): 0
SG&A to revenue (%): 60.38288595176455
Free cash flow (dilution-adjusted): 15607894.736842107
Buyback yield (%): 0
Retained earnings: 45468421.05263158
Receivables turnover: 89.22796352583586
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.417448433014705
FCF margin (%): 40.407412454012814
Rule of 40 score: 40.407412454012814
Financial ratios for TAM.L — annual report dated 2023-03-31
Total revenue: 39909876.54320987
Operating income: 20308641.97530864
Net income: 16509876.543209875
Capital expenditures: 109876.54320987653
Operating cash flow: 16334567.901234567
Depreciation & amortization: 1439506.172839506
Net tangible assets: 35591358.02469136
Owner earnings: 17839506.172839504
Return on net tangible assets (%): 50.12313989385687
Capex to operating income (%): 0.5410334346504558
Buffett classification: The Great
Stock price: 0.04925925925925926
P/E ratio: 0.1811268421520975
Shares outstanding: 60706999
Book value: 51581481.48148148
P/B ratio: 0.0579739417462483
Market cap (USD): 2990381.802592593
Debt to equity: 0.006246858619946866
Current ratio: 3.8579193527998985
Quick ratio: 3.8579193527998985
Effective tax rate (%): 16.397849462365592
Interest coverage ratio: 26.53225806451613
COGS to revenue (%): 0
SG&A to revenue (%): 49.11374392922326
Free cash flow (dilution-adjusted): 14188888.888888888
Buyback yield (%): 0
Retained earnings: 51158024.69135802
Receivables turnover: 116.28417266187051
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 37.35664812081299
FCF margin (%): 35.552324682154236
Revenue growth (%): 3.3230214362975365
Rule of 40 score: 38.87534611845177
Financial ratios for TAM.L — annual report dated 2024-03-31
Total revenue: 46591139.24050633
Operating income: 22344303.797468353
Net income: 16437974.683544302
Capital expenditures: 145569.62025316455
Operating cash flow: 16696202.531645568
Depreciation & amortization: 1424050.6329113923
Net tangible assets: 37713924.05063291
Owner earnings: 17716455.69620253
Return on net tangible assets (%): 46.975901188158694
Capex to operating income (%): 0.6514842510763653
Buffett classification: The Great
Stock price: 0.06658227848101266
P/E ratio: 0.24589466713383648
Shares outstanding: 60706999
Book value: 54853164.55696203
P/B ratio: 0.07368782358886786
Market cap (USD): 4042010.313164557
Debt to equity: 0.015207458346794663
Current ratio: 3.7050918505732953
Quick ratio: 3.7050918505732953
Effective tax rate (%): 22.864306608560682
Interest coverage ratio: 50.005665722379604
COGS to revenue (%): 0
SG&A to revenue (%): 52.04173119243622
Free cash flow (dilution-adjusted): 14670886.075949367
Buyback yield (%): 102.65602428309953
Retained earnings: 58091139.24050633
Receivables turnover: 41.92141230068337
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.80157835400225
FCF margin (%): 31.488575542695685
Revenue growth (%): 16.740875382219595
Rule of 40 score: 48.229450924915284
Financial ratios for TAM.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 45477333.333333336
Buffett classification: The Gruesome
Stock price: 0.08413333333333332
Shares outstanding: 60706999
Book value: 63181333.333333336
P/B ratio: 0.08083846783649179
Market cap (USD): 5107482.182533333
Debt to equity: 0.01200776600683746
Current ratio: 4.394964594807238
Quick ratio: 4.394964594807238
Buyback yield (%): 0
Retained earnings: 65749333.333333336
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TAM.L — annual report dated 2025-03-31
Total revenue: 58842857.14285714
Operating income: 27057142.85714286
Net income: 20962337.66233766
Capital expenditures: 88311.68831168831
Operating cash flow: 24353246.753246754
Depreciation & amortization: 1464935.0649350649
Net tangible assets: 48442857.14285714
Owner earnings: 22338961.038961038
Return on net tangible assets (%): 46.11404519986059
Capex to operating income (%): 0.3263895555342229
Buffett classification: The Great
Stock price: 0.07545454545454545
P/E ratio: 0.21851661247134627
Shares outstanding: 60706999
Book value: 65651948.051948056
P/B ratio: 0.06977125814804558
Market cap (USD): 4580619.015454546
Debt to equity: 0.016774806140212057
Current ratio: 3.5684650997151
Quick ratio: 3.5684650997151
Effective tax rate (%): 25.90294498981293
Interest coverage ratio: 169.38211382113823
COGS to revenue (%): 0
SG&A to revenue (%): 54.01796552561301
Free cash flow (dilution-adjusted): 21862337.662337665
Buyback yield (%): 1.4176045795553087
Retained earnings: 67735064.93506493
Receivables turnover: 145.22115384615384
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 40.68425472084985
FCF margin (%): 37.15376635988436
Revenue growth (%): 26.296240233806458
Rule of 40 score: 63.450006593690816
Financial ratios for TAM.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 48442857.14285714
Buffett classification: The Gruesome
Stock price: 0.07545454545454545
Shares outstanding: 60706999
Book value: 65651948.051948056
P/B ratio: 0.06977125814804558
Market cap (USD): 4580619.015454546
Debt to equity: 0.016774806140212057
Current ratio: 3.5684650997151
Quick ratio: 3.5684650997151
Buyback yield (%): 0
Retained earnings: 67735064.93506493
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TAM.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 57840540.54054054
Buffett classification: The Gruesome
Stock price: 0.09054054054054055
Shares outstanding: 60706999
Book value: 75562162.16216217
P/B ratio: 0.0727406991379927
Market cap (USD): 5496444.504054055
Debt to equity: 0.012912225481078761
Current ratio: 4.330717703349283
Quick ratio: 4.330717703349283
Buyback yield (%): 0
Retained earnings: 74282432.43243243
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UCM.AX — annual report dated 2021-06-30
Total revenue: 2900812.781954887
Gross profit: 2536096.2406015038
Operating income: -1077236.0902255639
Net income: -694919.5488721804
Capital expenditures: 4142.857142857142
Depreciation & amortization: 297933.83458646614
Net tangible assets: 1960837.5939849622
Owner earnings: -401128.5714285714
Return on net tangible assets (%): -20.457001266146047
Buffett classification: The Gruesome
Stock price: 0.12030075187969924
Shares outstanding: 260147121
Book value: 2313983.458646617
P/B ratio: 13.524683652640789
Market cap (USD): 31295894.255639095
Debt to equity: 0.46462663414779953
Current ratio: 3.6371761159737996
Quick ratio: 2.694043748386179
Interest coverage ratio: -15.000303623590506
COGS to revenue (%): 12.572908655883586
R&D to revenue (%): 21.146704799614113
SG&A to revenue (%): 87.56171785921552
Free cash flow (dilution-adjusted): 16260.902255639097
Buyback yield (%): 0.026115030502297968
Retained earnings: -26270953.383458644
Inventory turnover: 0.5420555003648546
Receivables turnover: 9.541061810340137
Capitalized R&D asset: 613426.3157894737
ROCI (R&D-adjusted, %): -17.086137468006637
FCF margin (%): 0.5605636584612921
Rule of 40 score: 0.5605636584612921
Financial ratios for UCM.AX — annual report dated 2022-06-30
Total revenue: 1730815.8620689656
Gross profit: 1493247.5862068967
Operating income: -1796580
Net income: -1360215.8620689656
Capital expenditures: 4017.9310344827586
Depreciation & amortization: 286655.8620689655
Net tangible assets: 3764307.5862068967
Owner earnings: -1077577.9310344828
Return on net tangible assets (%): -28.626192370222963
Buffett classification: The Gruesome
Stock price: 0.041379310344827586
Shares outstanding: 260147121
Book value: 4093280
P/B ratio: 2.629849034312926
Market cap (USD): 10764708.455172414
Debt to equity: 0.22106072594004372
Current ratio: 7.044754564184295
Quick ratio: 6.0714075254632265
Interest coverage ratio: -33.091231279295755
COGS to revenue (%): 13.725797242121814
R&D to revenue (%): 1.72551672860676
SG&A to revenue (%): 160.54418028093588
Free cash flow (dilution-adjusted): -746777.9310344828
Buyback yield (%): 0.3514806018809129
Retained earnings: -25457021.379310347
Inventory turnover: 0.3949859938517424
Receivables turnover: 7.379792692788356
Capitalized R&D asset: 440861.1488203267
ROCI (R&D-adjusted, %): -37.132750601251615
Rosenberg metric: -1.7000389900985433
FCF margin (%): -43.146006886128646
Revenue growth (%): -40.33341714308941
Rule of 40 score: -83.47942402921805
Financial ratios for UCM.AX — annual report dated 2023-06-30
Total revenue: 1764348.3443708608
Gross profit: 1487061.5894039734
Operating income: -1931455.6291390727
Net income: -1715819.8675496688
Capital expenditures: 11384.1059602649
Depreciation & amortization: 253426.49006622517
Net tangible assets: 1686147.0198675497
Owner earnings: -1473777.4834437084
Return on net tangible assets (%): -87.40504037183405
Buffett classification: The Gruesome
Stock price: 0.033112582781456956
Shares outstanding: 260147121
Book value: 2015913.2450331124
P/B ratio: 4.273072316328131
Market cap (USD): 8614143.079470199
Debt to equity: 0.35859940887553965
Current ratio: 3.079844704112279
Quick ratio: 2.4594529416751514
Interest coverage ratio: -28.338350321132562
COGS to revenue (%): 15.716100273031037
R&D to revenue (%): 1.8239103719512972
SG&A to revenue (%): 164.7403352493801
Free cash flow (dilution-adjusted): -1043681.4569536424
Buyback yield (%): 4.939766371660135
Retained earnings: -26161303.973509934
Inventory turnover: 0.5554873049440271
Receivables turnover: 7.241746174128136
Capitalized R&D asset: 254620.71321258158
ROCI (R&D-adjusted, %): -73.75115128970666
Rosenberg metric: -0.20712840005169705
FCF margin (%): -59.153934101703875
Revenue growth (%): 1.937380112856809
Rule of 40 score: -57.21655398884707
Financial ratios for WOCKPHARMA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.4761967559013587
Shares outstanding: 162492169
Market cap (USD): 564854750.7371753
Buyback yield (%): 0
Retained earnings: 168271132.79704604
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WOCKPHARMA.NS — annual report dated 2023-03-31
Total revenue: 322289890.37758833
Gross profit: 181120584.65286237
Operating income: -18148599.269183923
Net income: -68087697.92935444
Capital expenditures: 4506699.147381242
Operating cash flow: 18635809.987819735
Depreciation & amortization: 30572472.59439708
Net tangible assets: 147259439.70767358
Owner earnings: -42021924.48233861
Return on net tangible assets (%): -28.53598014888337
Buffett classification: The Gruesome
Stock price: 1.8745432399512791
Shares outstanding: 162492169
Book value: 446041412.91108406
P/B ratio: 0.6828930859939925
Market cap (USD): 304598596.9439708
Debt to equity: 0.596395412342982
Current ratio: 0.6427947598253275
Quick ratio: 0.45123726346433773
Interest coverage ratio: -0.5102739726027397
COGS to revenue (%): 43.80196523053666
SG&A to revenue (%): 9.221466364323506
Free cash flow (dilution-adjusted): -6942752.740560292
Buyback yield (%): 0
Retained earnings: 86479902.55785628
Inventory turnover: 1.7613981762917934
Receivables turnover: 3.3199498117942285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.5075329566854987
FCF margin (%): -2.154195011337868
Rule of 40 score: -2.154195011337868
Financial ratios for WOCKPHARMA.NS — annual report dated 2024-03-31
Total revenue: 334452572.2508694
Gross profit: 188271975.05696127
Operating income: -6355678.1388655715
Net income: -55522244.87348603
Capital expenditures: 839429.1881520567
Operating cash flow: 26262141.743614342
Depreciation & amortization: 26741815.565415516
Net tangible assets: 127713155.0545629
Owner earnings: -29619858.496222567
Return on net tangible assets (%): -23.192488262910796
Buffett classification: The Gruesome
Stock price: 7.026151631477927
Shares outstanding: 162492169
Book value: 439141383.8589759
P/B ratio: 2.5998338127211813
Market cap (USD): 1141694618.321737
Debt to equity: 0.6433642818132168
Current ratio: 0.782515227517019
Quick ratio: 0.5532067359369401
Interest coverage ratio: -0.18213058419243988
COGS to revenue (%): 43.707422015059166
SG&A to revenue (%): 8.246683399067766
Free cash flow (dilution-adjusted): 239836.91090058762
Buyback yield (%): 0
Retained earnings: 28780429.30807051
Inventory turnover: 1.9046875000000003
Receivables turnover: 4.5129449838187705
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0909839440098805
FCF margin (%): 0.07171029042667623
Revenue growth (%): 3.773832886607616
Rule of 40 score: 3.8455431770342923
Financial ratios for WOCKPHARMA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 113115145.72384138
Buffett classification: The Gruesome
Stock price: 11.68597706641185
Shares outstanding: 162492169
Book value: 443502150.0238891
P/B ratio: 4.281557057396984
Market cap (USD): 1898879760.4055185
Debt to equity: 0.6310261244276866
Current ratio: 0.8436974789915967
Quick ratio: 0.5676470588235295
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WOCKPHARMA.NS — quarterly report dated 2024-12-31
Total revenue: 84042429.18755099
Gross profit: 53502739.24699848
Operating income: 4779111.784590278
Net income: 2331274.0412635505
Capital expenditures: 0
Depreciation & amortization: 6411003.613474764
Owner earnings: 8742277.654738314
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.515328126821306
P/E ratio: 287.7837870595624
Shares outstanding: 162492169
Market cap (USD): 2683611489.073901
Effective tax rate (%): 4.761904761904763
Interest coverage ratio: 0.6833333333333333
COGS to revenue (%): 36.33841886269071
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WOCKPHARMA.NS — annual report dated 2025-03-31
Total revenue: 340776245.0315642
Gross profit: 200140285.24666822
Operating income: 21042787.000233807
Net income: -5494505.494505494
Capital expenditures: 9819967.266775778
Operating cash flow: -2571896.1889174655
Depreciation & amortization: 25368248.77250409
Net tangible assets: 212181435.5856909
Owner earnings: 10053776.011222819
Capex to operating income (%): 46.66666666666667
Buffett classification: The Good
Stock price: 16.622709767767535
Shares outstanding: 162492169
Book value: 544423661.4449381
P/B ratio: 4.961320302745903
Market cap (USD): 2701060164.822033
Debt to equity: 0.43397036718917753
Current ratio: 1.2580803134182175
Quick ratio: 0.9030362389813908
Interest coverage ratio: 0.7171314741035857
COGS to revenue (%): 41.269296740994854
SG&A to revenue (%): 8.713550600343051
Free cash flow (dilution-adjusted): -45358896.42272621
Buyback yield (%): 0
Retained earnings: 21978021.978021976
Inventory turnover: 1.6593103448275865
Receivables turnover: 4.40998487140696
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.954209748892171
FCF margin (%): -13.310463121783874
Revenue growth (%): 1.8907532204450985
Rule of 40 score: -11.419709901338775
Financial ratios for WOCKPHARMA.NS — quarterly report dated 2025-03-31
Total revenue: 86859948.56207621
Gross profit: 56464811.783960715
Operating income: 3039513.67781155
Net income: -2922609.305588029
Capital expenditures: 0
Depreciation & amortization: 6195931.727846621
Net tangible assets: 212181435.5856909
Owner earnings: 3273322.4222585917
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.622709767767535
Shares outstanding: 162492169
Book value: 544423661.4449381
P/B ratio: 4.961320302745903
Market cap (USD): 2701060164.822033
Debt to equity: 0.43397036718917753
Current ratio: 1.2580803134182175
Quick ratio: 0.9030362389813908
Interest coverage ratio: 0.5416666666666666
COGS to revenue (%): 34.99327052489906
Buyback yield (%): 0
Retained earnings: 21978021.978021976
Inventory turnover: 0.35862068965517246
Receivables turnover: 1.1240544629349472
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4267191859510914
Revenue growth (%): 3.352496354237428
Rule of 40 score: 3.352496354237428
Financial ratios for WOCKPHARMA.NS — quarterly report dated 2025-06-30
Total revenue: 86356190.0304236
Gross profit: 55464544.81628833
Operating income: 5265621.343318512
Net income: -10531242.686637023
Capital expenditures: 0
Depreciation & amortization: 6552773.227240815
Owner earnings: -3978469.4593962086
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.056166627662066
Shares outstanding: 162492169
Market cap (USD): 3258970017.1542244
Interest coverage ratio: 0.9375
COGS to revenue (%): 35.77235772357724
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.579966417194679
Rule of 40 score: -0.579966417194679
Financial ratios for WOCKPHARMA.NS — quarterly report dated 2025-12-31
Total revenue: 98919460.84438008
Gross profit: 63606995.655564226
Operating income: 12030745.237830011
Net income: 6795143.1435891725
Capital expenditures: 0
Depreciation & amortization: 7240726.30054584
Owner earnings: 14035869.444135012
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.1100590397683
P/E ratio: 96.30990770811476
Shares outstanding: 162492169
Market cap (USD): 2617758436.0900083
Effective tax rate (%): 8.955223880597016
Interest coverage ratio: 1.8
COGS to revenue (%): 35.6981981981982
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 14.54819950895286
Rule of 40 score: 14.54819950895286
Financial ratios for WSO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 275.63
Shares outstanding: 35534537
Market cap (USD): 9794384433.31
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WSO — annual report dated 2022-12-31
Total revenue: 7274344000
Gross profit: 2030289000
Operating income: 808907000
Net income: 703696000
Capital expenditures: 1863000
Operating cash flow: 571964000
Depreciation & amortization: 31683000
Net tangible assets: 1283335000
Owner earnings: 733516000
Return on net tangible assets (%): 57.15701667919911
Capex to operating income (%): 0.23031077738231961
Buffett classification: The Great
Stock price: 226.74
P/E ratio: 11.449689808354744
Shares outstanding: 35534537
Book value: 2248278000
P/B ratio: 3.58367644898896
Market cap (USD): 8057100919.38
Debt to equity: 0.173701383903592
Current ratio: 2.5357785028934763
Quick ratio: 1.0243171153044273
Effective tax rate (%): 15.157346219555276
Interest coverage ratio: 373.6290993071594
COGS to revenue (%): 72.08973070286476
SG&A to revenue (%): 16.790270022973893
Free cash flow (dilution-adjusted): 507491000
Buyback yield (%): 1.0811208755059623
Retained earnings: 1029516000
Inventory turnover: 3.8272940716245323
Receivables turnover: 9.73664386770355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.332436247236306
FCF margin (%): 6.976450385079397
Rule of 40 score: 6.976450385079397
Financial ratios for WSO — annual report dated 2023-12-31
Total revenue: 7283767000
Gross profit: 1992140000
Operating income: 768633000
Net income: 634139000
Capital expenditures: 1306000
Operating cash flow: 561954000
Depreciation & amortization: 35090000
Net tangible assets: 1554545000
Owner earnings: 667923000
Return on net tangible assets (%): 42.965819580649
Capex to operating income (%): 0.16991203864523122
Buffett classification: The Great
Stock price: 401.33
P/E ratio: 22.488879779054752
Shares outstanding: 35534537
Book value: 2616190000
P/B ratio: 5.451085637591306
Market cap (USD): 14261075734.21
Debt to equity: 0.1547257653304997
Current ratio: 3.3593970326342815
Quick ratio: 1.4671690926557417
Effective tax rate (%): 19.718062008634114
Interest coverage ratio: 156.22621951219512
COGS to revenue (%): 72.64959189386481
SG&A to revenue (%): 16.79772293649701
Free cash flow (dilution-adjusted): 496476000
Buyback yield (%): 0.019830201120214854
Retained earnings: 1183207000
Inventory turnover: 3.927610928316048
Receivables turnover: 9.129449558303001
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.47529638701167
FCF margin (%): 6.816198266638677
Revenue growth (%): 0.12953745382401494
Rule of 40 score: 6.945735720462692
Financial ratios for WSO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 469.07
Shares outstanding: 35534537
Market cap (USD): 16668185270.59
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WSO — annual report dated 2024-12-31
Total revenue: 7618317000
Gross profit: 2044713000
Operating income: 751274000
Net income: 635740000
Capital expenditures: 262000
Operating cash flow: 773102000
Depreciation & amortization: 40822000
Net tangible assets: 1996660000
Owner earnings: 676300000
Return on net tangible assets (%): 33.87156551440906
Capex to operating income (%): 0.03487409387254184
Buffett classification: The Great
Stock price: 454.41
P/E ratio: 25.39913951956775
Shares outstanding: 35534537
Book value: 3064238000
P/B ratio: 5.269580547650019
Market cap (USD): 16147248958.17
Debt to equity: 0.14602749525330605
Current ratio: 3.1303769383301776
Quick ratio: 1.722271854586996
Effective tax rate (%): 20.794274921384822
COGS to revenue (%): 73.1605681412312
SG&A to revenue (%): 16.97801496052212
Free cash flow (dilution-adjusted): 707990000
Buyback yield (%): 0.2456951032511746
Retained earnings: 1295972000
Inventory turnover: 4.0229963708175625
Receivables turnover: 8.677541048027473
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.491854668496764
FCF margin (%): 9.293259915543025
Revenue growth (%): 4.593090361072781
Rule of 40 score: 13.886350276615806
Financial ratios for WSO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 454.41
Shares outstanding: 35534537
Market cap (USD): 16147248958.17
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WSO — quarterly report dated 2025-03-31
Total revenue: 1531086000
Gross profit: 429623000
Operating income: 107042000
Net income: 94540000
Capital expenditures: 98000
Operating cash flow: -177644000
Depreciation & amortization: 10777000
Net tangible assets: 2002821000
Owner earnings: 105219000
Return on net tangible assets (%): 5.253539881996444
Capex to operating income (%): 0.09155284841464098
Buffett classification: The Great
Stock price: 490.1
P/E ratio: 46.05319595858896
Shares outstanding: 35534537
Book value: 3087860000
P/B ratio: 5.639982571651564
Market cap (USD): 17415476583.7
Debt to equity: 0.14887073895837247
Current ratio: 3.280965346828963
Quick ratio: 1.3611565397199772
Effective tax rate (%): 19.612261383444583
COGS to revenue (%): 71.93998246995923
SG&A to revenue (%): 21.06877079406382
Free cash flow (dilution-adjusted): -193985000
Buyback yield (%): 0
Retained earnings: 1266996000
Inventory turnover: 0.6201617035172767
Receivables turnover: 1.927562469155697
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0330266172581206
FCF margin (%): -12.669765120966424
Rule of 40 score: -12.669765120966424
Financial ratios for WSO — quarterly report dated 2025-06-30
Total revenue: 2062442000
Gross profit: 603488000
Operating income: 271869000
Net income: 216768000
Capital expenditures: 246000
Operating cash flow: -7446000
Depreciation & amortization: 10910000
Net tangible assets: 2084483000
Owner earnings: 227432000
Return on net tangible assets (%): 10.910715031017283
Capex to operating income (%): 0.09048475552563919
Buffett classification: The Great
Stock price: 428.3
P/E ratio: 48.88869607302093
Shares outstanding: 35534537
Book value: 3221819000
P/B ratio: 4.723866299472441
Market cap (USD): 15219442197.1
Debt to equity: 0.14094087842923517
Current ratio: 3.081210851271248
Quick ratio: 1.2576859436220955
Effective tax rate (%): 20.94471877985981
COGS to revenue (%): 70.73915290708781
SG&A to revenue (%): 16.436874346042217
Free cash flow (dilution-adjusted): -23095000
Buyback yield (%): 0
Retained earnings: 1329149000
Inventory turnover: 0.7470926987436771
Receivables turnover: 2.0304862080575896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.430963290026204
FCF margin (%): -1.11978906558342
Revenue growth (%): 34.70451692458817
Rule of 40 score: 33.58472785900475
Financial ratios for WSO — quarterly report dated 2025-09-30
Total revenue: 2067005000
Gross profit: 568915000
Operating income: 225260000
Net income: 189230000
Capital expenditures: 26000
Operating cash flow: 354937000
Depreciation & amortization: 10993000
Net tangible assets: 2142749000
Owner earnings: 200197000
Return on net tangible assets (%): 9.342998176641315
Capex to operating income (%): 0.011542217881559087
Buffett classification: The Great
Stock price: 394.61
P/E ratio: 28.01442377116223
Shares outstanding: 35534537
Book value: 3301627000
P/B ratio: 4.2470829217140516
Market cap (USD): 14022283645.57
Debt to equity: 0.13857046843874246
Current ratio: 3.836717380169034
Quick ratio: 1.8644242892885992
Effective tax rate (%): 20.656617539151764
COGS to revenue (%): 72.47636072481683
SG&A to revenue (%): 16.62574594642974
Free cash flow (dilution-adjusted): 336987000
Buyback yield (%): 0.02607991745449637
Retained earnings: 1369136000
Inventory turnover: 0.9352622634983699
Receivables turnover: 2.194545394704013
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.0188812138014764
FCF margin (%): 16.30315359662894
Revenue growth (%): 0.2212425852460336
Rule of 40 score: 16.524396181874973
Financial ratios for WSO — quarterly report dated 2025-12-31
Total revenue: 1578757000
Gross profit: 428438000
Operating income: 95793000
Net income: 87050000
Capital expenditures: 87000
Operating cash flow: 399766000
Depreciation & amortization: 11072000
Net tangible assets: 2108440000
Owner earnings: 98035000
Return on net tangible assets (%): 4.649646183908482
Capex to operating income (%): 0.09082083241990542
Buffett classification: The Great
Stock price: 331.64
P/E ratio: 20.056015185265863
Shares outstanding: 35534537
Book value: 3222061000
P/B ratio: 3.6574955752482645
Market cap (USD): 11784673850.68
Debt to equity: 0.14859681427508667
Current ratio: 4.116390012009886
Quick ratio: 2.1848923429310254
Effective tax rate (%): 18.931252211812474
COGS to revenue (%): 72.86232143388754
SG&A to revenue (%): 21.070057013207226
Free cash flow (dilution-adjusted): 379812000
Buyback yield (%): 0
Retained earnings: 1319201000
Inventory turnover: 0.8297662078730911
Receivables turnover: 1.9829121770049776
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.591056738822141
FCF margin (%): 24.057660551940547
Revenue growth (%): -23.62103623358434
Rule of 40 score: 0.4366243183562055
Financial ratios for WSO — annual report dated 2025-12-31
Total revenue: 7239290000
Gross profit: 2030464000
Operating income: 692582000
Net income: 587588000
Capital expenditures: 457000
Operating cash flow: 569613000
Depreciation & amortization: 43752000
Net tangible assets: 2108440000
Owner earnings: 630883000
Return on net tangible assets (%): 29.92179051810818
Capex to operating income (%): 0.06598496640109042
Buffett classification: The Great
Stock price: 331.64
P/E ratio: 20.056015185265863
Shares outstanding: 35534537
Book value: 3222061000
P/B ratio: 3.6574955752482645
Market cap (USD): 11784673850.68
Debt to equity: 0.14859681427508667
Current ratio: 4.116390012009886
Quick ratio: 2.1848923429310254
Effective tax rate (%): 20.346059787765903
COGS to revenue (%): 71.95216657987177
SG&A to revenue (%): 18.48084549727943
Free cash flow (dilution-adjusted): 499719000
Buyback yield (%): 0.031031830378479106
Retained earnings: 1319201000
Inventory turnover: 3.7573123607371186
Receivables turnover: 9.09251790736026
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.733302624272294
FCF margin (%): 6.9028730718067655
Revenue growth (%): -4.975206466205068
Rule of 40 score: 1.9276666056016971
Financial ratios for 2715.HK — annual report dated 2022-12-31
Total revenue: 331312103.4396552
Gross profit: 59157713.333333336
Operating income: 20885467.869252875
Net income: 18367202.375
Capital expenditures: 8837953.112068964
Operating cash flow: 4572451.948275862
Depreciation & amortization: 5868770.2844827585
Net tangible assets: 106118735.2112069
Owner earnings: 15398019.547413794
Return on net tangible assets (%): 14.510180051399304
Capex to operating income (%): 42.31628023559866
Buffett classification: The Good
Shares outstanding: 96780000
Book value: 117852235.68965518
Debt to equity: 0.5054627064748464
Current ratio: 1.5913769751881046
Quick ratio: 0.9764366294731796
Effective tax rate (%): 15.355666851620775
Interest coverage ratio: 10.657896068763518
COGS to revenue (%): 82.14441527515513
R&D to revenue (%): 8.062222479045495
SG&A to revenue (%): 1.4933495014968874
Free cash flow (dilution-adjusted): -4265501.163793104
Retained earnings: 59598110.272988506
Inventory turnover: 3.8626574255704895
Receivables turnover: 5.532210816257016
Capitalized R&D asset: 26711118.879310347
ROCI (R&D-adjusted, %): 24.149261835423587
FCF margin (%): -1.2874570894057353
Rule of 40 score: -1.2874570894057353
Financial ratios for 2715.HK — annual report dated 2023-12-31
Total revenue: 302016260.1940928
Gross profit: 57855632.22644163
Operating income: 11921345.52180028
Net income: 9072999.189873418
Capital expenditures: 12432130.11673699
Operating cash flow: -4404087.473980309
Depreciation & amortization: 7644268.704641351
Net tangible assets: 189770535.6413502
Owner earnings: 4285137.77777778
Return on net tangible assets (%): 2.2580627510459883
Capex to operating income (%): 104.28462201689103
Buffett classification: The Gruesome
Shares outstanding: 96780000
Book value: 208128158.96343178
Debt to equity: 0.02080459987677244
Current ratio: 2.570726557471239
Quick ratio: 1.7278694497506177
Effective tax rate (%): 0.8199003277677283
Interest coverage ratio: 10.077302358522417
COGS to revenue (%): 80.84353730184583
R&D to revenue (%): 9.960088732100521
SG&A to revenue (%): 2.2147781538649634
Free cash flow (dilution-adjusted): -16839902.541490857
Retained earnings: 63754800.52180027
Inventory turnover: 3.2983478711064262
Receivables turnover: 3.2734775510934475
Capitalized R&D asset: 47977537.14984117
ROCI (R&D-adjusted, %): 8.812731853068748
Rosenberg metric: -0.04874678267035308
FCF margin (%): -5.575826457379671
Revenue growth (%): -8.842370363598349
Rule of 40 score: -14.41819682097802
Financial ratios for 2715.HK — annual report dated 2024-12-31
Total revenue: 402927949.4561644
Gross profit: 68630782.92054795
Operating income: 23831415.53561644
Net income: 18571443.83561644
Capital expenditures: 3766792.906849315
Operating cash flow: -17793215.793150686
Depreciation & amortization: 8013323.2671232885
Net tangible assets: 198675396.31506848
Owner earnings: 22817974.195890415
Return on net tangible assets (%): 11.485052814342765
Capex to operating income (%): 15.80599734505817
Buffett classification: The Great
Shares outstanding: 96780000
Book value: 214673033.27397263
Debt to equity: 0.2313901240780666
Current ratio: 1.9527345141570336
Quick ratio: 1.3957104694696312
Effective tax rate (%): -8.243901054706612
Interest coverage ratio: 27.658351215184894
COGS to revenue (%): 82.96698379618998
R&D to revenue (%): 7.076131997640429
SG&A to revenue (%): 1.5259896458758868
Free cash flow (dilution-adjusted): -21562748.426027395
Retained earnings: 76606932.55753425
Inventory turnover: 3.751228245888125
Receivables turnover: 2.9178282879011306
Capitalized R&D asset: 57480711.41454768
ROCI (R&D-adjusted, %): 8.67775522524522
Rosenberg metric: 0.3582034955968403
FCF margin (%): -5.351514695153522
Revenue growth (%): 33.41266764816571
Rule of 40 score: 28.061152953012186
Financial ratios for 2715.HK — quarterly report dated 2024-12-31
Total revenue: 104019971.01917809
Gross profit: 20053392.482191782
Operating income: 7033191.997260273
Net income: 6056873.894520548
Capital expenditures: 2557375.11369863
Net tangible assets: 198675396.31506848
Owner earnings: 3499498.780821918
Return on net tangible assets (%): 1.7614152762389632
Capex to operating income (%): 36.36151429812859
Buffett classification: The Good
Shares outstanding: 96780000
Book value: 214673033.27397263
Debt to equity: 0.2313901240780666
Current ratio: 1.9527345141570336
Quick ratio: 1.3957104694696312
Effective tax rate (%): -48.2246339494459
COGS to revenue (%): 80.72159385768857
R&D to revenue (%): 7.881630921131917
SG&A to revenue (%): -3.977410107462055
Free cash flow (dilution-adjusted): -14643146.04520548
Retained earnings: 76606932.55753425
Inventory turnover: 0.9422090063840505
Receivables turnover: 0.7532672140417838
Capitalized R&D asset: 8198470.2
ROCI (R&D-adjusted, %): 5.524777584960196
FCF margin (%): -14.077244880702509
Rule of 40 score: -14.077244880702509
Financial ratios for 2715.HK — quarterly report dated 2025-03-31
Total revenue: 137336399.96143252
Gross profit: 19971051.315426998
Operating income: 9594801.318181818
Net income: 6377979.610192837
Capital expenditures: 307101.54269972455
Net tangible assets: 207611309.61294767
Owner earnings: 6070878.067493113
Return on net tangible assets (%): 2.9241557595350303
Capex to operating income (%): 3.2007076802911767
Buffett classification: The Great
Shares outstanding: 96780000
Book value: 222894089.97796142
Debt to equity: 0.33664598145799823
Current ratio: 1.8109415692900066
Quick ratio: 1.3263888225116993
Effective tax rate (%): 16.447250042822194
Interest coverage ratio: 63.91879761494888
COGS to revenue (%): 85.45829705669044
R&D to revenue (%): 4.8173550787886
SG&A to revenue (%): 2.797896968431864
Free cash flow (dilution-adjusted): -9520474.384297522
Retained earnings: 83406988.93112947
Inventory turnover: 1.2123340605273316
Receivables turnover: 0.8251937200537874
Capitalized R&D asset: 12108957.072567495
ROCI (R&D-adjusted, %): 4.733345537922502
Rosenberg metric: -0.010043479424342434
FCF margin (%): -6.932229465000618
Revenue growth (%): 32.02887735482246
Rule of 40 score: 25.096647889821845
Financial ratios for 2715.HK — quarterly report dated 2025-06-30
Total revenue: 124046450.29288703
Gross profit: 14940107.454672245
Operating income: 3982912.0013947003
Net income: 5280703.223152022
Capital expenditures: 2132857.080892608
Net tangible assets: 210323883.8214784
Owner earnings: 3147846.142259414
Return on net tangible assets (%): 1.4966660395693747
Capex to operating income (%): 53.550193429976446
Buffett classification: The Good
Shares outstanding: 96780000
Book value: 226056012.30264992
Debt to equity: 0.3156741044346371
Current ratio: 1.8651572077601648
Quick ratio: 1.27505391955658
Effective tax rate (%): -1.0470250475845366
Interest coverage ratio: 6.850172535001835
COGS to revenue (%): 87.95603790402946
R&D to revenue (%): 5.378269362620188
SG&A to revenue (%): -0.3434550319233983
Free cash flow (dilution-adjusted): -4516331.527196653
Retained earnings: 85002498.57043236
Inventory turnover: 0.9752762342507009
Receivables turnover: 0.9068191779383958
Capitalized R&D asset: 13809755.363360446
ROCI (R&D-adjusted, %): 1.435379098137019
Rosenberg metric: -0.7604228414507702
FCF margin (%): -3.6408389893730195
Revenue growth (%): -9.676931732794534
Rule of 40 score: -13.317770722167554